AP&T: CONTENTS LISTING FOR THE 15th JUNE 2017 ISSUE

The contents listing for the 15th June 2017 issue of Alimentary Pharmacology & Therapeutics is listed below and, as a member of the New Zealand Society of Gastroenterology, you have free access to all these articles when you log-in via the Members’ Area of the NZSG website - www.nzsg.org.nz

Yours sincerely

Roy

Professor R E Pounder
Co-Editor
Alimentary Pharmacology & Therapeutics
website: www.APandT.org
Follow AP&T on Twitter: @APandT

------------------------------------------------------------------------------------------------------

CONTENTS LIST FOR 15th JUNE 2017 ISSUE OF
ALIMENTARY PHARMACOLOGY & THERAPEUTICS


SYSTEMATIC REVIEWS WITH META-ANALYSES

Systematic review with meta-analysis: proximal disease extension in limited ulcerative colitis (pages 1481–1492)
G. Roda, N. Narula, R. Pinotti, A. Skamnelos, K. H. Katsanos, R. Ungaro, J. Burisch, J. Torres and J.-F. Colombel

Systematic review with meta-analysis: the efficacy and safety of tenofovir to prevent mother-to-child transmission of hepatitis B virus (pages 1493–1505)
M. H. Hyun, Y.-S. Lee, J. H. Kim, J. H. Je, Y. J. Yoo, J. E. Yeon and K. S. Byun


SYSTEMATIC REVIEW

Systematic review: quality of trials on the symptomatic effects of the low FODMAP diet for irritable bowel syndrome (pages 1506–1513)
L. R. Krogsgaard, M. Lyngesen and P. Bytzer


REVIEW ARTICLE

Review article: delivering precision oncology in intermediate-stage liver cancer (pages 1514–1523)
D. J. Pinato, J. Howell, R. Ramaswami and R. Sharma


RANDOMISED CLINICAL TRIAL

Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms (pages 1524–1533)
C. Coyle, G. Crawford, J. Wilkinson, S. J. Thomas and P. Bytzer


PAEDIATRIC INFLAMMATORY BOWEL DISEASE

A rising incidence and poorer male outcomes characterise early onset paediatric inflammatory bowel disease (pages 1534–1541)
A. Coughlan, R. Wylde, L. Lafferty, S. Quinn, A. Broderick, B. Bourke, S. Hussey and the DOCHAS Study


LOWER GI BLEEDING ON ASPIRIN

The risk of lower gastrointestinal bleeding in low-dose aspirin users (pages 1542–1550)
W.-C. Chen, K.-H. Lin, Y.-T. Huang, T.-J. Tsai, W.-C. Sun, S.-K. Chuah, D.-C. Wu and P.-I. Hsu


INVITED EDITORIALS
Editorial: visceral fat as a predictor of post-operative recurrence of Crohn's disease (pages 1551–1552)
R. W. Stidham and A. K. Waljee

Editorial: visceral fat as a predictor of post-operative recurrence of Crohn's disease—Authors’ reply (pages 1552–1553)
D. Q. Holt, G. T. Moore, B. J. G. Strauss, A. L. Hamilton, P. De Cruz and M. A. Kamm

Editorial: evidence is growing for protective effects of 5-aminosalicylates against colitis-associated cancer (pages 1553–1554)
P. D. Collins

Editorial: evidence is growing for protective effects of 5-aminosalicylates against colitis-associated cancer—authors’ reply (pages 1554–1555)
S. Bonovas, G. Fiorino, T. Lytras, G. Nikolopoulos, L. Peyrin-Biroulet and S. Danese

Editorial: is it time for therapeutic drug monitoring of anti-TNF agents during pregnancy? Maybe, maybe not (pages 1555–1556)
S. Kane

Editorial: is it time for therapeutic drug monitoring of anti-TNF agents during pregnancy? Maybe, maybe not. Author's reply (pages 1556–1557)
C. H. Seow


LETTERS TO THE EDITORS

Letter: hepatitis B virus reactivation in patients with chronic hepatitis C during direct-acting anti-viral therapy (page 1558)
R. Huang, X. Yan, J. Xia, J. Wang and C. Wu

Letter: hepatitis B reactivation in patients with chronic hepatitis C during direct-acting antiviral therapy—authors' reply (pages 1559–1560)
M.-C. Londoño, J. A. Carrión and X. Forns